Related Experiment Videos
State of the evidence: current status and prospects of meta-analysis in infectious diseases
1Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina 45110, Greece. jioannid@otenet.gr
Abstract:
Meta-analysis is increasingly applied in infectious diseases to summarize clinical data and to evaluate the strength, diversity, and deficiencies of evidence for medical questions of interest. We present an overview of the current status of meta-analysis in the area of infectious diseases and the lessons learnt from its applications. Recently published meta-analyses show that several important areas of research on infectious diseases lack sufficient randomized evidence. Often evidence is scattered across a large number of small trials, making meta-analysis a promising way to integrate diverse results. Quality of trials in the field is often poor. There are several examples where evidence was accumulated primarily for marketing rather than for scientific purposes. Finally, meta-analyses are also raising the problem of what constitutes clinically significant treatment benefits, as well as interesting issues about the reproducibility of clinical evidence and its evolving nature. The increasing applications of meta-analytic methods in the study of infectious diseases may enhance data sharing and international collaborations.
Insights
Meta-analysis in infectious diseases synthesizes scattered trial data but often reveals insufficient evidence and poor trial quality. This method highlights issues in clinical significance and evidence reproducibility, promoting collaboration.
Area of Science:
- Infectious Diseases
- Medical Research Methodology
Background:
- Meta-analysis is a key tool for summarizing clinical data in infectious diseases.
- Its application helps evaluate evidence strength, diversity, and deficiencies.
Purpose of the Study:
- To provide an overview of meta-analysis in infectious diseases.
- To discuss lessons learned from its application in this field.
Main Methods:
- Review of recently published meta-analyses in infectious diseases.
- Analysis of common issues identified in these studies.
Main Results:
- Many infectious disease research areas lack sufficient randomized evidence.
- Evidence is often scattered across numerous small, low-quality trials.
- Some evidence accumulation appears marketing-driven rather than scientific.
Conclusions:
- Meta-analysis reveals critical gaps in infectious disease evidence quality and quantity.
- It raises important questions about clinical significance, reproducibility, and the dynamic nature of evidence.
- Increased use of meta-analytic methods can foster data sharing and international research collaborations.